Hypothesis

Aged stem cells enter senescence with pre‑existing chromatin closures at enhancers of immune‑recruiting SASP genes (e.g., CCL2, CXCL10). This forces the senescent secretome to rely on alternative chemokines that preferentially attract immunosuppressive myeloid‑derived suppressor cells (MDSCs) rather than NK cells or macrophages. Consequently, senescent cells become double agents: they still halt proliferation but actively block their own clearance, turning a self‑limiting program into a persistent inflammatory niche.

Mechanistic basis

• In young cells, accessible chromatin at CCL2/CXCL10 enhancers allows H2A.J‑mediated remodeling to boost transcription of immunogenic SASP components.
• With age, stable nucleosome remodeling (e.g., increased H3K9me3) closes these enhancers before senescence entry, as shown by ATAC‑seq in aged HSCs and NSCs (1, 3).
• When the preferred enhancers are inaccessible, transcription factors such as NF‑κB redirect to secondary sites, driving expression of CCL7, CXCL5, and IL‑6 that recruit MDSCs (4).
• MDSCs secrete arginase‑1 and ROS, which further suppress NK‑cell cytotoxicity and macrophage phagocytosis, creating a feedback loop that retains senescent cells.

Testable predictions

1. Senescent cells isolated from aged tissues will show higher CCL7/CXCL5 and lower CCL2/CXCL10 mRNA compared with senescent cells from young tissues.
2. Co‑culture of these senescent cells with immune cells will yield increased MDSC markers (CD11b+Gr1+) and decreased NK‑cell activation (CD107a).
3. Artificial opening of the CCL2/CXCL10 enhancers in aged senescent cells using CRISPR‑dCas9‑p300 will restore immunogenic SASP secretion and enhance NK‑cell‑mediated clearance in vivo.

Experimental approach

• Isolate senescent cells (p16^INK4a^+) from young (3 mo) and aged (24 mo) mouse liver and muscle.
• Perform qPCR and ELISA for SASP chemokines (CCL2, CXCL10, CCL7, CXCL5).
• Flow‑sort immune cells from co‑cultures to quantify MDSC vs NK/macrophage phenotypes.
• Use AAV‑delivered dCas9‑p300 guided to CCL2/CXCL10 enhancers in senescent cells of aged mice; assess senescence burden (SA‑β‑gal, p16) and tissue repair after injury.

Falsifiable outcome If enhancing chromatin accessibility does not shift the secretome toward immunogenic factors or improve clearance, the hypothesis that pre‑existing enhancer closure drives maladaptive senescence via MDSC skewing would be refuted.